Ran Zhang, Author at MediaMedic

World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (1)

By Ran Zhang 2025.02.18

Editor's Note: Breast cancer is one of the most common malignant tumors in women and is often referred to as the "pink killer," posing a serious threat to women's health. The…

World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (2)

By Ran Zhang 2025.02.18

Editor's Note: Breast cancer is one of the most common malignant tumors in women and is often referred to as the "pink killer," posing a serious threat to women's health. The…

Professor Yehui Shi: The Epigenetic Regulation of HR+ Metastatic Breast Cancer—A Review of the Development Path of HDACi Entinostat

By Ran Zhang 2025.02.18

Editor's Note: Histone deacetylases (HDACs) are overexpressed in various tumors and are closely related to tumor progression and drug resistance. In hormone receptor-positive (HR+) breast cancer, HDAC overexpression leads to…

National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part I

By Ran Zhang 2025.02.18

Healthy living for all, together we uphold, and start a new chapter! September is the National Healthy Lifestyle Promotion Month. We focus on breast cancer, a significant disease threatening women's…

National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part2

By Ran Zhang 2025.02.18

Spatially resolved transcriptomics: advances and applications

By Ran Zhang 2024.03.15

In January 2023, a review by Professor Tao Cheng from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published in the international academic journal ——Blood…

Gene Therapy Milestone: Elevated FIX Levels Achieved in Chinese Hemophilia B Patients

By Ran Zhang 2024.03.06

In January 2023, Professor Jianmin Wang from Department of Hematology, Shanghai Changhai Hospital published a commentary on Blood Science. The title of the study is "Big stride in gene therapy for hemophilia B…

Academician Xiaojun Huang: Conquering Leukemia with the Beijing Protocol

By Ran Zhang 2024.03.01

Congratulations! Mr. Xiaojun Huang has been elected as an academician of the Chinese Academy of Engineering. Huang Xiaojun, an expert in hematologic diseases, serves as the director of the Hematology Department…

Dr.Yanhang Gao’s Team: Non-Invasive Screening for ANA-Positive DILI Patients with AIH-Like Histological Features, Aiding in Precise Liver Biopsy!

By Ran Zhang 2024.02.27

Drug-induced liver injury (DILI) can mimic all features of acute and chronic liver diseases, including autoimmune hepatitis (AIH). Both conditions exhibit similarities in serology and histology, including the presence of…

Dr.Guohong Han: Combining Targeted Therapy to Reduce Postoperative Liver Cancer Recurrence and Prolong Survival in Cirrhotic Patients with Anticoagulation

By Ran Zhang 2024.02.27

The 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and the 2023 EASL Congress concluded successfully on June 24th in Vienna, Austria, three…